Literature DB >> 16897149

[Acupuncture. Clinical studies on efficacy and effectiveness in patients with chronic pain].

C M Witt1, B Brinkhaus, S N Willich.   

Abstract

In Germany, acupuncture is one of the most frequently used complementary and alternative therapies. In the year 2000, we initiated three large projects in co-operation with statutory health insurance companies to assess the effectiveness, safety and costs of acupuncture in patients with chronic headache, low back pain and pain due to osteoarthritis. Our findings showed that acupuncture was more effective than conventional standard treatment, treatment without acupuncture or a waiting list control. A significant difference between acupuncture and sham acupuncture was only seen for arthritis of the knee; for the other diagnoses, both forms of acupuncture showed similar effects. Whether the effects of acupuncture are due primarily to specific or unspecific mechanisms appears to depend on the diagnosis and should be investigated in further studies.

Entities:  

Mesh:

Year:  2006        PMID: 16897149     DOI: 10.1007/s00103-006-0003-y

Source DB:  PubMed          Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz        ISSN: 1436-9990            Impact factor:   1.513


  3 in total

1.  [Is supplemental ear acupuncture for surgical tooth removal with local anesthesia effective? : A pilot study].

Authors:  E A Lux; G Wahl; J Erlenwein; C Wiese; S Wirz
Journal:  Schmerz       Date:  2017-10       Impact factor: 1.107

2.  Acupuncture for chronic nonspecific low back pain.

Authors:  Jinglan Mu; Andrea D Furlan; Wai Yee Lam; Marcos Y Hsu; Zhipeng Ning; Lixing Lao
Journal:  Cochrane Database Syst Rev       Date:  2020-12-11

3.  Objectifying specific and nonspecific effects of acupuncture: a double-blinded randomised trial in osteoarthritis of the knee.

Authors:  Max Karner; Frank Brazkiewicz; Andrew Remppis; Joachim Fischer; Oliver Gerlach; Wolfgang Stremmel; Shanmuga Velayutham Subramanian; Henry Johannes Greten
Journal:  Evid Based Complement Alternat Med       Date:  2013-01-10       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.